Cyclacel Pharmaceuticals Inc (CYCC)
2.300
+0.51
(+28.49%)
USD |
NASDAQ |
Apr 24, 16:00
2.68
+0.38
(+16.53%)
After-Hours: 20:00
Cyclacel Pharmaceuticals Total Assets (Quarterly): 8.805M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.805M |
| September 30, 2023 | 12.50M |
| June 30, 2023 | 16.44M |
| March 31, 2023 | 22.06M |
| December 31, 2022 | 28.05M |
| September 30, 2022 | 31.02M |
| June 30, 2022 | 35.35M |
| March 31, 2022 | 39.63M |
| December 31, 2021 | 43.14M |
| September 30, 2021 | 45.00M |
| June 30, 2021 | 46.33M |
| March 31, 2021 | 51.82M |
| December 31, 2020 | 36.80M |
| September 30, 2020 | 27.21M |
| June 30, 2020 | 29.17M |
| March 31, 2020 | 12.99M |
| December 31, 2019 | 15.31M |
| September 30, 2019 | 17.08M |
| June 30, 2019 | 19.46M |
| March 31, 2019 | 21.51M |
| December 31, 2018 | 19.82M |
| September 30, 2018 | 20.71M |
| June 30, 2018 | 22.73M |
| March 31, 2018 | 24.78M |
| December 31, 2017 | 26.00M |
| Date | Value |
|---|---|
| September 30, 2017 | 27.85M |
| June 30, 2017 | 16.08M |
| March 31, 2017 | 17.07M |
| December 31, 2016 | 19.66M |
| September 30, 2016 | 22.65M |
| June 30, 2016 | 18.88M |
| March 31, 2016 | 21.46M |
| December 31, 2015 | 24.76M |
| September 30, 2015 | 27.05M |
| June 30, 2015 | 30.79M |
| March 31, 2015 | 35.36M |
| December 31, 2014 | 29.39M |
| September 30, 2014 | 31.63M |
| June 30, 2014 | 37.61M |
| March 31, 2014 | 33.78M |
| December 31, 2013 | 35.52M |
| September 30, 2013 | 37.99M |
| June 30, 2013 | 37.51M |
| March 31, 2013 | 17.49M |
| December 31, 2012 | 19.35M |
| September 30, 2012 | 20.53M |
| June 30, 2012 | 21.80M |
| March 31, 2012 | 25.34M |
| December 31, 2011 | 26.00M |
| September 30, 2011 | 28.95M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
8.805M
Minimum
Dec 2023
51.82M
Maximum
Mar 2021
28.32M
Average
28.05M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Corvus Pharmaceuticals Inc | 45.55M |
| Oragenics Inc | 4.966M |
| Relmada Therapeutics Inc | 97.55M |
| Alpine Immune Sciences Inc | 379.85M |
| MAIA Biotechnology Inc | 7.567M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.198M |
| Shareholders Equity (Quarterly) | 0.607M |
| Current Ratio | 0.9121 |